UY29582A1 - Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-ciclofenil) (4-(4-piridilmetil) ftalazin-ilo) no micronizado, y sus sales. - Google Patents

Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-ciclofenil) (4-(4-piridilmetil) ftalazin-ilo) no micronizado, y sus sales.

Info

Publication number
UY29582A1
UY29582A1 UY29582A UY29582A UY29582A1 UY 29582 A1 UY29582 A1 UY 29582A1 UY 29582 A UY29582 A UY 29582A UY 29582 A UY29582 A UY 29582A UY 29582 A1 UY29582 A1 UY 29582A1
Authority
UY
Uruguay
Prior art keywords
micronized
salts
immediate release
pharmaceutical formulations
piridilmetil
Prior art date
Application number
UY29582A
Other languages
English (en)
Inventor
Juergens Kai
Backensfels Thomas
Wagner Thorsten
Funke Adrian
Thode Kai
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29582A1 publication Critical patent/UY29582A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formulaciones farmacéuticas sólidas de liberación inmediata y con una carga elevada de droga que comprenden (4-clorofenil) (4-(4-piridilmetil)-ftalazin-1-ilo) no micronizado, y sales del mismo aceptables para uso farmacéutico.
UY29582A 2005-06-07 2006-06-07 Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-ciclofenil) (4-(4-piridilmetil) ftalazin-ilo) no micronizado, y sus sales. UY29582A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090166A EP1731153A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof

Publications (1)

Publication Number Publication Date
UY29582A1 true UY29582A1 (es) 2007-01-31

Family

ID=34938467

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29582A UY29582A1 (es) 2005-06-07 2006-06-07 Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-ciclofenil) (4-(4-piridilmetil) ftalazin-ilo) no micronizado, y sus sales.

Country Status (21)

Country Link
EP (2) EP1731153A1 (es)
JP (1) JP2008542420A (es)
KR (1) KR20080031005A (es)
CN (1) CN101242840A (es)
AR (1) AR053889A1 (es)
AU (1) AU2006256852A1 (es)
BR (1) BRPI0613393A2 (es)
CA (1) CA2610975A1 (es)
CR (1) CR9563A (es)
DO (1) DOP2006000127A (es)
EC (1) ECSP078038A (es)
GT (1) GT200600242A (es)
IL (1) IL187905A0 (es)
MX (1) MX2007015494A (es)
NO (1) NO20080065L (es)
PE (1) PE20070319A1 (es)
RU (1) RU2007147951A (es)
TW (1) TW200716115A (es)
UY (1) UY29582A1 (es)
WO (1) WO2006131393A1 (es)
ZA (1) ZA200800112B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

Also Published As

Publication number Publication date
DOP2006000127A (es) 2006-12-15
JP2008542420A (ja) 2008-11-27
ECSP078038A (es) 2008-01-23
EP1888072A1 (en) 2008-02-20
RU2007147951A (ru) 2009-07-20
IL187905A0 (en) 2008-03-20
EP1731153A1 (en) 2006-12-13
PE20070319A1 (es) 2007-04-12
AU2006256852A1 (en) 2006-12-14
KR20080031005A (ko) 2008-04-07
GT200600242A (es) 2007-02-09
AU2006256852A8 (en) 2006-12-14
CN101242840A (zh) 2008-08-13
CR9563A (es) 2008-02-20
NO20080065L (no) 2008-03-06
BRPI0613393A2 (pt) 2011-01-11
MX2007015494A (es) 2008-02-22
CA2610975A1 (en) 2006-12-14
WO2006131393A1 (en) 2006-12-14
TW200716115A (en) 2007-05-01
AR053889A1 (es) 2007-05-23
ZA200800112B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
CL2011002781A1 (es) Compuestos (e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol y (r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol; composicion farmaceutica que los comprende; y uso en el tratamiento del cancer.
UY31647A1 (es) Forma de dosificación farmacéutica para la administración oral de inhibidor de tirosina quinasa
ECSP11011469A (es) Sales de disacarina, ácido difumárico, ácido di-1-hidroxi-2-naftoico y ácido monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato de 4-(dimetilamino)butilo
CR20110110A (es) Composicion farmaceutica
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
CL2019003619A1 (es) Preparación sólida para administración oral.
ECSP088296A (es) Compuestos terapéuticos
CO6290686A2 (es) Dabigatrán para la cateterización cardiaca intervencionista percutánea
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
UY29952A1 (es) Composiciones faramacéuticas que comprenden 4-(4-fluoro-2-metil-1h-indol-5-iloxi)-6-metoxi-7-(3-(pirrolidin-1-il)propoxi)quinazolina o una sal farmacéuticamente aceptable del mismo, procesos de preparación y uso
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
CR20120058A (es) Composiciones nuevas de 1 - [2 - (2,4-dimetil-fenilsulfanil)-fenil] piperazina
ES2555778T3 (es) Mejora de la biodisponibilidad de principios activos con función amidina en medicamentos
RS54293B1 (en) PHARMACEUTICAL COMBINATION
AR058047A1 (es) Administracion de inhibidores de dipeptidil peptidasa
ECSP13012832A (es) Compuestos de pirazol como antagonistas de crth2
UY29585A1 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) (4-(4-piridilmetil) ftalazin-1-ilo) micronizado, y sus sales.
UY29582A1 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-ciclofenil) (4-(4-piridilmetil) ftalazin-ilo) no micronizado, y sus sales.
EA200702386A1 (ru) Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
CU20070271A7 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales
UY29637A1 (es) Formulación de liberación prolongada de principios activos de medicamentos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160905